Veracyte (VCYT) Tops Q1 EPS by 3c, Reiterates FY Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Veracyte Announces First Quarter 2015 Financial Results
May 14, 2015 4:05 PM EDTSOUTH SAN FRANCISCO, Calif., May 14, 2015 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT) today reported financial results for the first quarter ended March 31, 2015 and provided an update on recent business progress. For the first quarter of 2015, revenue was $11.2 million, an increase of 50%, compared to $7.5 million for the first quarter of 2014.
"Our results demonstrate continued execution on our strategy to increase the breadth and depth of Afirma® adoption across both community and institutional accounts," said Bonnie H. Anderson, Veracyte's president and... More
